Polyoma virus-like particles elicit polarized cytokine responses in APCs from tumor-susceptible and -resistant mice

Journal of Immunology

Volumn 176, Issue 2, 2006, Pages 1148-1153

  Velupillai, Palanivel ^a   Garcea, Robert L ^b   Benjamin, Thomas L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CAPSID PROTEIN; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 12; SIALIC ACID; SIALIDASE;

ANIMAL CELL; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; CANCER SUSCEPTIBILITY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMORAL IMMUNITY; MOUSE; NONHUMAN; POLYOMA VIRUS; PRIORITY JOURNAL; SPLEEN CELL; TH1 CELL; TUMOR IMMUNITY; TUMOR RESISTANCE; VIRUS INFECTION; VIRUS PARTICLE;

EID: 30744449965     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.2.1148     Document Type: Article

References (35)

1. Stehle, T., Y. Yan, T. L. Benjamin, and S. C. Harrison. 1994. Structure of mutine polyomavirus complexed with an oligosaccharide receptor fragment. Nature 369: 160-163.
2. Tsai, B., J. M. Gilbert, T. Stehle, W. Lencer, T. L. Benjamin, and T. A. Rapoport. 2003. Gangliosides are receptors for murine polyoma virus and SV40. EMBO J. 22: 4346-4355.
3. Gross, L. 1983. The polyoma virus. In Oncogenic Viruses, Vol. 2. L. Gross, ed. Pergamon Press, Elmsford, pp. 737-825.
4. Benjamin, T. L. 2001. Polyoma virus: old findings and new challenges. Virology 289: 167-173.
5. Lukacher, A. E., Y. Ma, J. P. Carroll, S. R. Abromson-Leeman, J. C. Laning, M. E. Dorf, and T. L. Benjamin. 1995. Susceptibility to tumors induced by polyoma virus is conferred by an endogenous mouse mammary tumor virus superantigen. J. Exp. Med. 181: 1683-1692.
6. + T cells in vivo during infection and tumor rejection. J. Immunol. 163: 3369-3378.
7. Tevethia, S., T. Beachy, T. Schell, J. Lippolis, R. Newmaster, L. Mylin, and M. J. Tevethia. 2001. Role of CTL hose responses and cheir implication for tumorigenicity testing and the use of tumour cells as vaccine substrate. Dev. Biol. 106: 109-121.
8. k-restricted epitope in the middle T protein. J. Immunol. 160: 1724-1734.
9. Moser, J. M., and A. E. Lukacher. 2001. Immunity to polyoma virus infection and tumorigenesis. Viral. Immunol. 14: 199-216.
10. + T-lymphocyte responses to multiple epitopes from simian virus 40 (SV40) large T antigen in C57BL/6 mice immunized with SV40, SV40 T-Ag-transformed cells, or vaccinia virus recombinants expressing full-length T antigen or epitope minigenes. J. Virol. 74: 6922-6934.
11. Lukacher, A. E., R. Freund, J. P. Carroll, R. T. Bronson, and T. L. Benjamin. 1993. Pyvs: a dominantly acting gene in C3H/BiDa mice conferring susceptibility to tumor induction by polyoma virus. Virology 196: 241-248.
12. Velupillai, P., I. Yoshizawa, D. C. Dey, S. R. Nahill, J. P. Carroll, R. T. Bronson, and T. L. Benjamin. 1999. Wild-derived inbred mice have a novel basis of susceptibility to polyomavirus-induced tumors. J. Virol. 73: 10079-10085.
13. + T cell responses. Nat. Immunol. 3: 189-195.
14. Velupillai, P., J. P. Carroll, and T. L. Benjamin. 2002. Susceptibility to polyomavims-induced tumors in inbred mice: role of innate immune responses. J. Virol. 76: 9657-9663.
15. Montross, L., S. Watkins, R. B. Moreland, H. Mamon, D. L. Caspar, and R. L. Garcea. 1991. Nuclear assembly of polyomavirus capsids in insect cells expressing the major capsid protein VP1. J. Virol. 65: 4991-4998.
16. Garcea, R. L., and P. A. Estes. 1998. Purification of papovavirus virus-like particles (VLPs) from Sf9 insect cells. In Cell Biology: A Laboratory Handbook, Vol. 1. J. E. Celis, ed. Academic Press, New York, pp. 521-527.
17. Garcea, R. L., D. M. Salunke, and D. L. Caspar. 1987. Site-directed mutation affecting polyomavirus capsid self-assembly in vitro. Nature 329: 86-87.
18. Kantor, A. B., and L. A. Herzenberg. 1993. Origin of mutine B cell lineages. Annu. Rev. Immunol. 11: 501-538.
19. Lenz, P., P. M. Day, Y. Y. Pang, S. A. Frye, P. N. Jensen, D. R. Lowy, and J. T. Schiller. 2001. Papillomavirus-like particles induce acute activation of dendritic cells. J. Immunol. 166: 5346-5355.
20. Takeda, K., and S. Akira. 2005. Toll-like receptors in innate immunity. Int. Immunol. 17: 1-14.
21. Medzhitov, R., and C. A. Janeway, Jr. 2002. Decoding the patterns of self and nonself by the innate immune system. Science 296: 298-300.
22. Rassa, J. C., J. L. Meyers, Y. Zhang, R. Kudaravalli, and S. R. Ross. 2002. Murine retroviruses activate B cells via interaction with Toll-like receptor 4. Proc. Natl. Acad. Sci. USA 99: 2281-2286.
23. Rassa, J. C., and S. R. Ross. 2003. Viruses and Toll-like receptors. Microbes Infect. 5: 961-968.
24. Zuniga, E. I., B. Hahm, K. H. Edelmann, and M. B. A. Oldstone. 2005. Immunosuppressive viruses and dendritic cells: a multifront war. In ASM News, Vol. 71. Am. Soc. Microbiol., Washington, DC, pp. 285-290.
25. Ardavin, C., F. Luthi, M. Andersson, L. Scarpellino, P. Martin, H. Diggelmann, and H. Acha-Orbea. 1997. Retrovirus-induced target cell activation in the early phases of infection: the mouse mammary tumor virus model. J. Virol. 71: 7295-7299.
26. Fiorentino, D. F., M. W. Bond, and T. R. Mosmann. 1989. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170: 2081-2095.
27. O'Garra, A., R. Chang, N. Go, R. Hastings, G. Haughton, and M. Howard. 1992. Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10. Eur. J. Immunol. 22: 711-717.
28. Go, N. F., B. E. Castle, R. Barrett, R. Kastelein, W. Dang, T. R. Mosmann, K. W. Moore, and M. Howard. 1990. Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells. J. Exp. Med. 172: 1625-1631.
29. Bieback, K., E. Lien, I. M. Klagge, E. Avota, J. Schneider-Schaulies, W. P. Duprex, H. Wagner, C. J. Kirschning, V. Ter Meulen, and S. Schneider-Schaulies. 2002. Hemagglutinin protein of wild-type measles virus activates Toll-like receptor 2 signaling. J. Virol. 76: 8729-8736.
30. Zhu, H., J. P. Cong, and T. Shenk. 1997. Use of differential display analysis to assess the effect of human cytomegalovirus infection on the accumulation of cellular RNAs: induction of interferon-responsive RNAs. Proc. Natl. Acad. Sci. USA 94: 13985-13990.
31. Choe, J., M. S. Kelker, and I. A. Wilson. 2005. Crystal structure of human Toll-like receptor 3 (TLR3) ectodomain. Science 309: 581-585.
32. Triantafilou, M., S. Morath, A. Mackie, T. Hartung, and K. Triantafilou. 2004. Lateral diffusion of Toll-like receptors reveals that they are transiently confined within lipid rafts on the plasma membrane. J. Cell Sci. 117: 4007-4014.
33. Caldwell, S., A. Heitger, W. Shen, Y. Liu, B. Taylor, and S. Ladisch. 2003. Mechanisms of ganglioside inhibition of APC function. J Immunol. 171: 1676-1683.
34. Shen, W., and S. Ladisch. 2002. Ganglioside GD1a impedes lipopolysaccharide-induced maturation of human dendritic cells. Cell. Immunol. 220: 125-133.
35. West, A. P., B. A. Dancho, and S. B. Mizel. 2005. Gangliosides inhibit flagellin signaling in the absence of an effect on flagellin binding to Toll-like receptor 5. J. Biol. Chem. 280: 9482-9488.